Skip to main content
AVIR logo

AVIR · Atea Pharmaceuticals, Inc. · Analyst Estimates

Track AVIR — free
$5.33 +0.07 (+1.33%) At close · Sep 18
Market Cap
$419.47M
Shares
80.20M

Analyst Estimates

Compare analyst forecasts for Atea Pharmaceuticals, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 09:34 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-2.21
-1.985
-1.76
-1.925
-1.925
-1.925
-1.65
EPS
analysts
Publication date not stated
2
2
2
0
0
Revenue
USD
Publication date not stated
0
0
0
Revenue
analysts
Publication date not stated
1

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.76
-1.48
-1.2
-1.385
-1.385
-1.385
-1.38
EPS
analysts
Publication date not stated
2
2
2
0
0
Revenue
USD
Publication date not stated
0
30000000
60000000
Revenue
analysts
Publication date not stated
2

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.59
-0.505
-0.42
-0.545
-0.545
-0.545
-0.545
EPS
analysts
Publication date not stated
2
1
1
1
1
Revenue
USD
Publication date not stated
0
0
0
Revenue
analysts
Publication date not stated
1

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.72
-0.57
-0.42
-0.495
-0.495
-0.495
-0.5
EPS
analysts
Publication date not stated
2
1
1
1
1
Revenue
USD
Publication date not stated
0
0
0
Revenue
analysts
Publication date not stated
1
Key facts CIK 1593899 CUSIP 04683R106 13F (30d) 3 filings 3 filers Visit website Investor relations